Themis Medicare Ltd Hits Intraday High with 7.29% Surge on 7 Jan 2026

Intraday Trading Dynamics and Price Action

The stock demonstrated heightened volatility throughout the trading session, with an intraday volatility of 5.06% calculated from the weighted average price. This volatility accompanied a decisive upward momentum that saw Themis Medicare Ltd outperform its sector peers by 5.91% on the day. The stock’s closing price reflected a 5.44% gain compared to the Sensex’s marginal decline of 0.08%, underscoring its relative strength in a broadly subdued market environment.

Themis Medicare Ltd’s price movement today was characterised by a rebound following two consecutive days of losses, signalling a potential short-term trend reversal. The stock traded above its 5-day and 20-day moving averages, indicating positive momentum in the near term. However, it remained below its longer-term moving averages of 50-day, 100-day, and 200-day, suggesting that the broader trend still faces resistance at higher levels.

Market Context and Sector Performance

On the broader market front, the Sensex opened lower at 84,620.40, down 442.94 points or 0.52%, but recovered slightly to trade near 85,015.85, a marginal decline of 0.06%. The index remains close to its 52-week high of 86,159.02, just 1.34% away, supported by bullish moving averages where the 50-day moving average is positioned above the 200-day moving average. Mid-cap stocks led the market rally, with the BSE Mid Cap index gaining 0.39% on the day, providing a supportive backdrop for stocks like Themis Medicare Ltd.

Performance Metrics and Historical Trends

Examining Themis Medicare Ltd’s recent performance reveals a mixed picture. The stock’s one-week gain stands at 4.87%, outperforming the Sensex’s 0.27% decline over the same period. Month-to-date, the stock is essentially flat with a marginal -0.05% change, while the Sensex has declined by 0.84%. However, over the last three months, Themis Medicare Ltd has underperformed significantly, with a decline of 18.46% compared to the Sensex’s 3.74% gain.

Longer-term performance data shows a challenging period for the stock. Over one year, Themis Medicare Ltd has fallen by 60.02%, contrasting with the Sensex’s 8.69% rise. The three-year performance also reflects a decline of 18.85%, while the Sensex has appreciated by 41.89%. Despite these setbacks, the stock has delivered strong returns over five and ten years, with gains of 201.57% and 106.56% respectively, though these lag behind the Sensex’s 76.72% and 242.00% returns over the same periods.

Mojo Score and Market Capitalisation Insights

Themis Medicare Ltd currently holds a Mojo Score of 17.0, categorised as a Strong Sell grade as of 01 Feb 2025, an upgrade from its previous Sell rating. This score reflects the stock’s risk profile and market sentiment as assessed by MarketsMOJO. The company’s market capitalisation grade is rated at 3, indicating a mid-tier valuation within its sector.

Sector and Industry Positioning

Operating within the Pharmaceuticals & Biotechnology sector, Themis Medicare Ltd’s intraday surge today stands out against a backdrop of mixed sector performance. The sector has experienced varied momentum, with some stocks showing resilience while others face pressure. Themis Medicare Ltd’s ability to outperform its sector by nearly 6% today highlights its distinct trading action amid broader market fluctuations.

Summary of Today’s Trading Session

Themis Medicare Ltd’s strong intraday performance on 07 Jan 2026 was marked by a 7.29% rise to Rs 107.4, supported by high volatility and a rebound after two days of decline. The stock’s gains outpaced both the Pharmaceuticals & Biotechnology sector and the broader Sensex index, which traded lower for most of the session. Despite remaining below its longer-term moving averages, the stock’s position above the 5-day and 20-day averages indicates short-term positive momentum.

The broader market environment was characterised by cautious trading, with the Sensex hovering near its 52-week high but opening lower. Mid-cap stocks led the market rally, providing a favourable context for Themis Medicare Ltd’s performance. The company’s Mojo Score and market cap grade reflect a cautious stance, yet the stock’s price action today demonstrated notable resilience and strength.

Investors and market participants will note the stock’s ability to outperform its sector and the benchmark index in a volatile session, highlighting its active trading interest and dynamic price movement. Themis Medicare Ltd’s performance today adds a significant data point to its ongoing market narrative within the Pharmaceuticals & Biotechnology sector.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →